Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Philadelphia, PA
SEC filing record 1 source field available
Fiscal year end
30 September
abrdn Life Sciences Investors has filed 515 SEC EDGAR filings since 13 Dec 1995

SEC filing history

Showing 26-50 of 383 matching filings.

Per page
25
Current page
2
NPORT-P File 811-06565

NPORT-P filing

Filing date
28 Aug 2025
Reporting date
30 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Aug 2025
Reporting date
26 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Aug 2025
Reporting date
21 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
40-17G File 811-06565

40-17G

Filing date
29 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
22 Jul 2025
Reporting date
17 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
N-CSRS File 811-06565

N-CSRS

Filing date
09 Jun 2025
Reporting date
31 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
NPORT-P File 811-06565

NPORT-P filing

Filing date
29 May 2025
Reporting date
31 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 May 2025
Reporting date
20 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 May 2025
Reporting date
15 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 May 2025
Reporting date
13 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 May 2025
Reporting date
08 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 May 2025
Reporting date
07 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-48561

SCHEDULE 13G filing

Filing date
28 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Apr 2025
Reporting date
17 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Apr 2025
Reporting date
14 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 811-06565

DEF 14A

Filing date
14 Apr 2025
Reporting date
28 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Apr 2025
Reporting date
10 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Apr 2025
Reporting date
03 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Apr 2025
Reporting date
01 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-48561

SCHEDULE 13D/A filing

Filing date
01 Apr 2025
Reporting date
Not listed
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Apr 2025
Reporting date
31 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 Mar 2025
Reporting date
27 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Mar 2025
Reporting date
24 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
20 Mar 2025
Reporting date
11 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .